首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >Application of real-time PCR for testing antiviral compounds against Lassa virus SARS coronavirus and Ebola virus in vitro
【2h】

Application of real-time PCR for testing antiviral compounds against Lassa virus SARS coronavirus and Ebola virus in vitro

机译:实时荧光定量PCR在体外检测抗拉萨病毒SARS冠状病毒和埃博拉病毒的抗病毒化合物中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This report describes the application of real-time PCR for testing antivirals against highly pathogenic viruses such as Lassa virus, SARS coronavirus and Ebola virus. The test combines classical cell culture with a quantitative real-time PCR read-out. The assay for Lassa virus was validated with ribavirin, which showed an IC of 9 μg/ml. Small-scale screening identified a class of imidazole nucleosideucleotide analogues with antiviral activity against Lassa virus. The analogues contained either dinitrile or diester groups at the imidazole 4,5-positions, and many of which possessed an acyclic sugar or sugar phosphonate moiety at the imidazole 1-position. The IC values of the most active compounds ranged from 5 to 21 μg/ml. The compounds also inhibited replication of SARS coronavirus and Ebola virus in analogous assays, although to a lesser extent than Lassa virus.
机译:该报告描述了实时PCR在测试针对高致病性病毒(例如Lassa病毒,SARS冠状病毒和埃博拉病毒)的抗病毒药物中的应用。该测试将经典细胞培养与定量实时PCR读数结合在一起。用利巴韦林验证了对拉沙病毒的测定,IC值为9μg/ ml。小规模筛选鉴定出一类对拉沙病毒具有抗病毒活性的咪唑核苷/核苷酸类似物。类似物在咪唑的4,5-位上含有二腈或二酯基,其中许多在咪唑的1位上具有无环糖或糖膦酸酯部分。最具活性的化合物的IC值范围为5至21μg/ ml。该化合物在类似试验中也能抑制SARS冠状病毒和埃博拉病毒的复制,尽管程度要小于拉沙病毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号